143 related articles for article (PubMed ID: 1246336)
1. Editorial: Glomerulonephritis, complement and C3NeF.
Fearon DT
N Engl J Med; 1976 Feb; 294(9):495-7. PubMed ID: 1246336
[No Abstract] [Full Text] [Related]
2. Complement and mesangiocapillary glomerulonephritis: the role of complement deficiency in glomerulonephritis.
Peters DK; Williams DG
Adv Nephrol Necker Hosp; 1974; 4():67-78. PubMed ID: 4220000
[No Abstract] [Full Text] [Related]
3. [Partial lipodystrophy, hypocomplementemia and glomerulonephritis].
Habib R; Lévy M; Gubler MC; Broyer M; Habib M
Arch Fr Pediatr; 1977; 34(7 Suppl):CXCVII-CCXII. PubMed ID: 931525
[TBL] [Abstract][Full Text] [Related]
4. [Persistent C4 deficiency in a 26-month-old girl with mesangial glomerulonephritis and deposits of IgG and C3].
Buffatti G; Borgo G; Lupo A
Minerva Pediatr; 1977 Mar; 29(9):593-8. PubMed ID: 876007
[No Abstract] [Full Text] [Related]
5. [Serum levels and glomerular deposits of some components of complement in glomerular diseases. Correlations in 172 cases].
Rovati C; Barbiano di Belgiojoso G; Durante A; Minetti L
Minerva Nefrol; 1975; 22(6):252-61. PubMed ID: 1223702
[No Abstract] [Full Text] [Related]
6. Immunoglobulin and complement deposits in lupus glomerulonephritis.
Méry JP; Morel-Maroger L; Boelaert J
Proc Eur Dial Transplant Assoc; 1975; 11():506-11. PubMed ID: 1197274
[No Abstract] [Full Text] [Related]
7. Partial lipodystrophy and glomerulonephritis without complement activation.
Mery JP; Kourilsky O; Morel-Maroger L; Adam C
N Engl J Med; 1978 May; 298(18):1034. PubMed ID: 643001
[No Abstract] [Full Text] [Related]
8. C3 nephritic factor (C3NeF): dissociation of cell-bound and fluid phase stabilization of alternative pathway C3 convertase.
Ng YC; Peters DK
Clin Exp Immunol; 1986 Aug; 65(2):450-7. PubMed ID: 3641695
[TBL] [Abstract][Full Text] [Related]
9. Complement deposition in glomerular diseases.
di Belgiojoso GB; Tarantino A; Durante A; Guerra L
Proc Eur Dial Transplant Assoc; 1975; 11():515-21. PubMed ID: 1105561
[TBL] [Abstract][Full Text] [Related]
10. Biological significance of the C3 nephritic factor in membranoproliferative glomerulonephritis.
Schena FP; Pertosa G; Stanziale P; Vox E; Pecoraro C; Andreucci VE
Clin Nephrol; 1982 Nov; 18(5):240-6. PubMed ID: 7151338
[TBL] [Abstract][Full Text] [Related]
11. C3 requirements for formation of alternative pathway C5 convertase.
Daha MR; Fearon DT; Austen KF
J Immunol; 1976 Aug; 117(2):630-4. PubMed ID: 950465
[TBL] [Abstract][Full Text] [Related]
12. The complement abnormalities of lipodystrophy.
Sissons JG; West RJ; Fallows J; Williams DG; Boucher BJ; Amos N; Peters DK
N Engl J Med; 1976 Feb; 294(9):461-5. PubMed ID: 1246331
[TBL] [Abstract][Full Text] [Related]
13. [Proceedings: Recurrent hematuria and mesangial deposits of IgA-IgG with lowering of serum complement in a 7-year-old boy].
Beyer P; Freysz H; Haegy JM; Himy G
Pediatrie; 1975; 30(5):536-7. PubMed ID: 1178281
[No Abstract] [Full Text] [Related]
14. Serum and glomerular complement in 205 cases of glomerulonephritis.
Durante A; Rovati C; di Belgiojoso GB; Minetti L
Proc Eur Dial Transplant Assoc; 1976; 12():189-96. PubMed ID: 935112
[TBL] [Abstract][Full Text] [Related]
15. Transfer of C3 nephritic factor from mother to fetus. Is C3 nephritic factor IgG?
Davis AE; Arnaout MA; Alper CA; Rosen FS
N Engl J Med; 1977 Jul; 297(3):144-5. PubMed ID: 865586
[No Abstract] [Full Text] [Related]
16. Letter: Membranoproliferative nephritis and C3NeF.
N Engl J Med; 1976 Jun; 294(23):1293-5. PubMed ID: 1264160
[No Abstract] [Full Text] [Related]
17. Clearances of complement components, C3 proactivator and other serum proteins in chronic membranoproliferative glomerulonephritis (CMPGN).
Geiger H; Good RA; Day NK
Clin Nephrol; 1975; 3(4):139-47. PubMed ID: 1149337
[TBL] [Abstract][Full Text] [Related]
18. Complement activation in acute glomerulonephritis in children.
Levy M; Sich M; Pirotzky E; Habib R
Ric Clin Lab; 1980; 10(1):87-91. PubMed ID: 7008160
[No Abstract] [Full Text] [Related]
19. Effect of nephritic factor on C3 and on the terminal pathway of complement in vivo and in vitro.
Mollnes TE; Ng YC; Peters DK; Lea T; Tschopp J; Harboe M
Clin Exp Immunol; 1986 Jul; 65(1):73-9. PubMed ID: 3641694
[TBL] [Abstract][Full Text] [Related]
20. Evidence for activation of the alternate pathway in glomerulonephritis.
Michael AF; McLean RH
Adv Nephrol Necker Hosp; 1974; 4():49-66. PubMed ID: 4219999
[No Abstract] [Full Text] [Related]
[Next] [New Search]
